Orphazyme is now officially in American hands

The sale of embattled biotech firm Orphazyme to US-based Kempharm is now complete.

Photo: Orphazyme/PR

Orphazyme has announced that the sale of the firm and all of its assets to Kempharm is now complete.

This means that all company assets and employees are now in the hands of the US-based company.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs